BCM
ESPR

Bayesian Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bayesian Capital Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-65,900
Closed -$145K – 717
2024
Q4 		$145K Buy
+65,900
New +$154K 0.02% 596
2024
Q2 		– Sell
-51,200
Closed -$137K – 847
2024
Q1 		$137K Buy
+51,200
New +$124K 0.01% 693
2023
Q4 		– Sell
-17,600
Closed -$17.2K – 834
2023
Q3 		$17.2K Buy
+17,600
New +$25.5K ﹤0.01% 655
2022
Q4 		– Sell
-27,630
Closed -$185K – 849
2022
Q3 		$185K Buy
+27,630
New +$190K 0.04% 532
2022
Q2 		– Sell
-29,795
Closed -$138K – 863
2022
Q1 		$138K Buy
+29,795
New +$128K 0.02% 679
2018
Q2 		– Sell
-3,199
Closed -$231K – 638
2018
Q1 		$231K Buy
+3,199
New +$235K 0.06% 463
2017
Q4 		– Sell
-11,127
Closed -$558K – 592
2017
Q3 		$558K Buy
+11,127
New +$537K 0.13% 247

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return